Patrice Wendling is an Author at Medscape. She specializes in topics such as Endocrinology, Hematology, Immunology, Immunotherapy, and Surgery, providing insightful analysis and coverage on these critical areas of medicine. Patrice's work has been featured in Medscape, prIME Oncology LLC, MDEdge, MedCentral, and Oncology News Central.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .
March 28, 2015 | Cardiology News Author and Disclosure Information
July 1, 2011 | Cardiology News Author and Disclosure Information
May 16, 2013 | Cardiology News Author and Disclosure Information AT THE AATS ANNUAL MEETING
May 22, 2013 | Cardiology News Author and Disclosure Information AT THE AATS ANNUAL MEETING
By: Patrice Wendling
May 13, 2013 | Cardiology News Author and Disclosure Information AT THE AATS ANNUAL MEETING
GLP-1 receptor agonists may offer additional cardioprotective benefits over SGLT2 inhibitors in pulmonary arterial hypertension (PAH), suggest
Americans with idiopathic pulmonary fibrosis (IPF) derived the same benefits from nerandomilast (Jascayd) as their counterparts around the globe, according to a FIBRONEER-IPF subgroup analysis.
August 30, 2014 | Cardiology News Author and Disclosure Information FROM THE ESC CONGRESS 2014
Discover the top highlights from ASCO 2026 in urothelial carcinoma, including new treatments and research breakthroughs.
Explore the latest advances in castration-sensitive prostate cancer, including new treatments and strategies for managing the disease.
